Complement Activation in Inflammatory Skin Diseases

by Jenny Giang, Marc A. J. Seelen, Martijn B. A. van Doorn, Robert Rissmann, Errol P. Prens, Jeffrey Damman
Published 2018-04-01

Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll‐Like Receptor Ligands in Human Peripheral Blood Mononuclear Cells

by Hendrika W. Grievink, Silvana M. G. Jirka, Tess D. Woutman, Mascha Schoonakker, Robert Rissmann, Karen E. Malone, Gary Feiss, Matthijs Moerland
Published 2020-09-01

Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers

by Tessa Niemeyer‐van der Kolk, Salma Assil, Thomas P. Buters, Melanie Rijsbergen, Erica S. Klaassen, Gary Feiss, Edwin Florencia, Errol P. Prens, Jacobus Burggraaf, Martijn B.A. vanDoorn, Robert Rissmann, Matthijs Moerland
Published 2020-05-01

Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial

by Tessa Niemeyer‐van der Kolk, Hein van derWall, Geretta K. Hogendoorn, Rianne Rijneveld, Sascha Luijten, Dirk C.J.G. vanAlewijk, Ellen H.A. van denMunckhof, Marieke L. deKam, Gary L. Feiss, Errol P. Prens, Jacobus Burggraaf, Robert Rissmann, Martijn B.A. vanDoorn
Published 2020-09-01

Inter- and Intra-patient Variability Over Time of Lesional Skin Microbiota in Adult Patients with Atopic Dermatitis

by Ellen H.A. van den Munckhof, Tessa Niemeyer-van der Kolk, Hein van der Wall, Dirk C.J.G. van Alewijk, Martijn B.A. van Doorn, Jacobus Burggraaf, Thomas P. Buters, Martin J. Becker, Gary L. Feiss, Wim G.V. Quint, Leen-Jan van Doorn, Cornelis W. Knetsch, Robert Rissmann
Published 2020-01-01